Imagine a world in which devastating diseases such as cancer are detected sooner; thus, providing doctors the ability to treat patients earlier with better outcomes. Amplified Sciences is a startup life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases. The company leverages IP licensed from Purdue University and has developed a platform that can scale to point of care. The lead assay is an ultra-sensitive molecular sensing technology revolutionizing pancreatic cancer, enabling early detection of debilitating diseases across oncology and chronic kidney disease.
Is this your company?
Something looks off?